New shot could ease stuffy noses and polyps for sinusitis sufferers
NCT ID NCT07519577
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests a biologic drug called CM512 in 120 people with chronic sinusitis and nasal polyps. Participants receive the drug as a shot under the skin. The goal is to see if it is safe and helps control symptoms. All participants have been in a previous CM512 study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CM512 (a biologic drug given as a shot under the skin)
- What this could lead to
- If it works, this could point toward a new treatment option to control symptoms and reduce nasal polyps in people with chronic sinusitis.
- What could go wrong
- This is an early phase 2 study with no placebo group, so results may not prove effectiveness. Side effects are possible, and the drug may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Beijing Tong-Ren hospital
Beijing, China
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.